In this review we discuss the rationale and underlying radiobiologic concepts for hypofractionation, and review the clinical trials and ASTRO guidelines supporting hypofractionated radiation in the treatment of breast cancer.
Michael J. Eblan, MD
Advertisement
Articles by Michael J. Eblan, MD
Advertisement
Latest Updated Articles
Hypofractionation for Breast Cancer: Lessons Learned From Our Neighbors to the North and Across the PondPublished: June 15th 2014 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Subcutaneous Mosunetuzumab in R/R Follicular Lymphoma
2
SABCS 2025: The Top 5 Takeaways for Breast Cancer Research
3
Pyrotinib Combo Sustains Survival Benefits in HER2+ Breast Cancer Trial
4
Novel Anti-BCMA Agent Shows Preliminary Responses in R/R Multiple Myeloma
5